IL133076A - Solubilized sertraline pharmaceutical compositions - Google Patents

Solubilized sertraline pharmaceutical compositions

Info

Publication number: IL133076A
Authority: IL; Israel
Prior art keywords: pharmaceutical compositions; sertraline; solubilized; solubilized sertraline; pharmaceutical
Prior art date: 1997-07-01

Application number

IL13307698A

Other languages

English (en)

Other versions

IL133076A0 (en

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-06-15

Publication date

2003-12-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL133076(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-15 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2001-03-19 Publication of IL133076A0 publication Critical patent/IL133076A0/xx

2003-12-10 Publication of IL133076A publication Critical patent/IL133076A/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title 1
229960002073 sertraline Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IL13307698A 1997-07-01 1998-06-15 Solubilized sertraline pharmaceutical compositions IL133076A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5141397P	1997-07-01	1997-07-01
PCT/IB1998/000933 WO1999001120A1 (fr)	1997-07-01	1998-06-15	Compositions de sertraline solubilisee

Publications (2)

Publication Number	Publication Date
IL133076A0 IL133076A0 (en)	2001-03-19
IL133076A true IL133076A (en)	2003-12-10

Family

ID=21971159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13307698A IL133076A (en)	1997-07-01	1998-06-15	Solubilized sertraline pharmaceutical compositions

Country Status (34)

Country	Link
EP (1)	EP0999829A1 (fr)
JP (1)	JP2000514100A (fr)
KR (1)	KR100366373B1 (fr)
CN (1)	CN1261794A (fr)
AP (1)	AP1192A (fr)
AR (3)	AR015917A1 (fr)
AU (1)	AU742535B2 (fr)
BG (1)	BG103918A (fr)
BR (1)	BR9810739A (fr)
CA (1)	CA2290974C (fr)
CO (1)	CO4940495A1 (fr)
DZ (1)	DZ2548A1 (fr)
EA (1)	EA002481B1 (fr)
HN (1)	HN1998000102A (fr)
HR (1)	HRP980377A2 (fr)
HU (1)	HUP0002236A3 (fr)
ID (1)	ID23429A (fr)
IL (1)	IL133076A (fr)
IS (1)	IS5260A (fr)
MA (1)	MA24587A1 (fr)
NO (1)	NO996520L (fr)
OA (1)	OA11243A (fr)
PA (1)	PA8454301A1 (fr)
PE (1)	PE97199A1 (fr)
PL (1)	PL337804A1 (fr)
SK (1)	SK181099A3 (fr)
TN (1)	TNSN98124A1 (fr)
TR (1)	TR199903297T2 (fr)
TW (1)	TW550087B (fr)
UA (1)	UA67741C2 (fr)
UY (1)	UY25071A1 (fr)
WO (1)	WO1999001120A1 (fr)
YU (1)	YU68299A (fr)
ZA (1)	ZA985708B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DZ3227A1 (fr)	1999-12-23	2001-07-05	Pfizer Prod Inc	Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
US20030086972A1 (en) *	2000-08-09	2003-05-08	Appel Leah E.	Hydrogel-driven drug dosage form
MXPA03001771A (es)	2000-08-30	2003-06-04	Pfizer Prod Inc	Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
US20040191207A1 (en) *	2003-03-31	2004-09-30	Lipari John M.	Alpha-hydroxy acid ester drug delivery compositions and methods of use
CN101631593B (zh) *	2007-03-12	2014-08-13	帝斯曼知识产权资产管理有限公司	化妆品组合物
BR112012003592B8 (pt)	2009-08-19	2021-05-25	Eisai R&D Man Co Ltd	composição farmacêutica contendo derivado de quinolina
US20130035344A1 (en) *	2009-12-29	2013-02-07	Kowa Co., Ltd.	Pharmaceutical composition for oral administration
JPWO2011081117A1 (ja) *	2009-12-29	2013-05-09	興和株式会社	経口投与用固形医薬組成物
CN109908354A (zh) *	2017-12-12	2019-06-21	万特制药(海南)有限公司	盐酸舍曲林口服浓缩液及其制备工艺
CN114894736B (zh) *	2022-05-20	2025-03-21	中化地质矿山总局地质研究院	一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
ATE96999T1 (de) *	1989-08-30	1993-11-15	Pfizer	Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
ZA97976B (en) *	1996-04-05	1997-08-18	Alza Corp	Uniform drug delivery theraphy.

1998
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/pt not_active Application Discontinuation
- 1998-06-15 ID IDW991701A patent/ID23429A/id unknown
- 1998-06-15 SK SK1810-99A patent/SK181099A3/sk unknown
- 1998-06-15 EA EA199900962A patent/EA002481B1/ru unknown
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/xx unknown
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/fr not_active Ceased
- 1998-06-15 IL IL13307698A patent/IL133076A/xx not_active IP Right Cessation
- 1998-06-15 YU YU68299A patent/YU68299A/sh unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/zh active Pending
- 1998-06-15 CA CA002290974A patent/CA2290974C/fr not_active Expired - Fee Related
- 1998-06-15 JP JP11506774A patent/JP2000514100A/ja active Pending
- 1998-06-15 PL PL98337804A patent/PL337804A1/xx unknown
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/ko not_active Expired - Fee Related
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/hu unknown
- 1998-06-15 UA UA99116391A patent/UA67741C2/uk unknown
- 1998-06-15 EP EP98923019A patent/EP0999829A1/fr not_active Withdrawn
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-25 TW TW087110267A patent/TW550087B/zh active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25071A patent/UY25071A1/es not_active IP Right Cessation
- 1998-06-29 AR ARP980103146A patent/AR015917A1/es not_active Application Discontinuation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/es unknown
- 1998-06-30 MA MA25146A patent/MA24587A1/fr unknown
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/xx unknown
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/fr unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/fr active
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/es unknown
- 1998-07-01 CO CO98037137A patent/CO4940495A1/es unknown
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/hr not_active Application Discontinuation
1999
- 1999-11-19 IS IS5260A patent/IS5260A/is unknown
- 1999-11-23 BG BG103918A patent/BG103918A/xx unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/no not_active Application Discontinuation
2003
- 2003-06-19 AR ARP030102179A patent/AR040279A2/es unknown
- 2003-06-19 AR ARP030102180A patent/AR040280A2/es unknown

Also Published As

Publication number	Publication date
CO4940495A1 (es)	2000-07-24
ZA985708B (en)	2000-01-10
CA2290974A1 (fr)	1999-01-14
PA8454301A1 (es)	2000-09-29
BR9810739A (pt)	2000-09-12
YU68299A (sh)	2002-06-19
ID23429A (id)	2000-04-20
NO996520D0 (no)	1999-12-28
AP1192A (en)	2003-07-23
SK181099A3 (en)	2000-07-11
BG103918A (en)	2000-07-31
EA199900962A1 (ru)	2000-08-28
AR040279A2 (es)	2005-03-23
JP2000514100A (ja)	2000-10-24
AU7544898A (en)	1999-01-25
MA24587A1 (fr)	1998-12-31
AR040280A2 (es)	2005-03-23
UA67741C2 (uk)	2004-07-15
KR20010013365A (fr)	2001-02-26
AR015917A1 (es)	2001-05-30
EA002481B1 (ru)	2002-06-27
OA11243A (en)	2003-07-24
HUP0002236A3 (en)	2003-12-29
KR100366373B1 (ko)	2003-01-14
TNSN98124A1 (fr)	2005-03-15
AU742535B2 (en)	2002-01-03
DZ2548A1 (fr)	2003-02-08
PL337804A1 (en)	2000-09-11
EP0999829A1 (fr)	2000-05-17
NO996520L (no)	2000-02-29
HRP980377A2 (en)	1999-04-30
HN1998000102A (es)	1999-01-08
HUP0002236A2 (hu)	2003-08-28
TW550087B (en)	2003-09-01
AP9801280A0 (en)	1998-06-30
CA2290974C (fr)	2004-04-27
IL133076A0 (en)	2001-03-19
TR199903297T2 (xx)	2000-07-21
WO1999001120A1 (fr)	1999-01-14
UY25071A1 (es)	2000-12-29
IS5260A (is)	1999-11-19
PE97199A1 (es)	1999-10-05
CN1261794A (zh)	2000-08-02

Legal Events

Date	Code	Title
2004-05-12	FF	Patent granted
2004-06-01	KB	Patent renewed
2009-07-27	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
EG24118A (en)	2008-07-06	Pharmaceutical compositions
GB9727053D0 (en)	1998-02-18	Pharmaceutical compositions
GB9706089D0 (en)	1997-05-14	Pharmaceutical composition
GB9610359D0 (en)	1996-07-24	Pharmaceutical compositions
GB9717444D0 (en)	1997-10-22	Pharmaceutical composition
IL131995A0 (en)	2001-03-19	Gastric-retained pharmaceutical compositions
AP9901657A0 (en)	1999-09-30	Pharmaceutical compositions
GB9723985D0 (en)	1998-01-14	Pharmaceutical compositions
AP9801280A0 (en)	1998-06-30	Solubilized sertraline compositions
GB9717428D0 (en)	1997-10-22	Pharmaceutical composition
GB9726735D0 (en)	1998-02-18	Pharmaceutical compositions
GB9606429D0 (en)	1996-06-05	Pharmaceutical compositions
HU9700632D0 (en)	1997-05-28	Pharmaceutical compositions
GB9717770D0 (en)	1997-10-29	Pharmaceutical composition
GB9610136D0 (en)	1996-07-24	Pharmaceutical compositions
GB9921495D0 (en)	1999-11-17	Pharmaceutical compositions
GB2321190B (en)	2000-09-20	Pharmaceutical composition
GB9726781D0 (en)	1998-02-18	Pharmaceutical composition
GB9718270D0 (en)	1997-11-05	Pharmaceutical compositions
HUP0004274A3 (en)	2002-03-28	Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof
GB9710505D0 (en)	1997-07-16	Pharmaceutical compositions
GB9825499D0 (en)	1999-01-13	Pharmaceutical compositions
GB9710527D0 (en)	1997-07-16	Pharmaceutical compositions
GB9722066D0 (en)	1997-12-17	Pharmaceutical compositions
GB9725563D0 (en)	1998-02-04	Pharmaceutical compositions